AstraZeneca ousts CEO

http://www.fiercebiotech.com/story/astrazenec...2013-01-15 Mackay's departure comes after a year of turmoil at AstraZeneca, which has been hammered by investors and analysts who have been upset with the company's inability to piece together the kind of pipeline needed to position the company for the future. After CEO David Brennan was sacked last year, Mackay had vowed to pick up the deal pace. But his efforts clearly didn't win him much affection with the new boss.

they're setting up for more aggressive pursuit of new agents...